Nutex Book Value Per Share from 2010 to 2025

NUTX Stock

USD 159.95 1.91 1.18%

Nutex Health Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Nutex Health according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

39.58640969

Current Value

41.57

Quarterly Volatility

18.02018854

Credit Downgrade

Yuan Drop

Covid

Check Nutex Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutex Health's main balance sheet or income statement drivers, such as Selling General Administrative of 29.8 M, Total Revenue of 503.9 M or Gross Profit of 206.1 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.0418 or PTB Ratio of 1.16. Nutex financial statements analysis is a perfect complement when working with Nutex Health Valuation or Volatility modules.

Build AI portfolio with Nutex Stock

Check out the analysis of Nutex Health Correlation against competitors.

For more information on how to buy Nutex Stock please use our How to Invest in Nutex Health guide.

Latest Nutex Health's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Nutex Health over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Nutex Health's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nutex Health's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 35.65 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Nutex Book Value Per Share Regression Statistics

	Arithmetic Mean	14.09
	Geometric Mean	3.99
	Coefficient Of Variation	127.91
	Mean Deviation	15.63
	Median	1.66
	Standard Deviation	18.02
	Sample Variance	324.73
	Range	50.5219
	R-Value	0.81
	Mean Square Error	121.69
	R-Squared	0.65
	Significance	0.0002
	Slope	3.05
	Total Sum of Squares	4,871

Nutex Book Value Per Share History

	2025	41.57
	2024	39.59
	2023	17.94
	2022	28.47
	2021	47.68
	2020	34.34
	2019	12.28

Other Fundumenentals of Nutex Health

Tangible Book Value Per Share

Nutex Health Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Current Deferred Revenue	Common Stock	Short Term Debt	Intangible Assets	Net Tangible Assets	Long Term Debt	Net Invested Capital	Short Long Term Debt	Net Working Capital	Property Plant Equipment	Capital Stock	Capital Surpluse	Short Term Investments
Total Assets		0.98	0.98	-0.76	0.76	0.94	0.71	0.99	0.96	-0.49	0.37	0.56	0.64	0.79	-0.09	0.82	0.55	0.88	-0.18	-0.69	-0.71	0.71
Total Stockholder Equity	0.98		0.93	-0.64	0.72	0.95	0.61	0.94	0.97	-0.47	0.34	0.5	0.52	0.86	0.06	0.91	0.53	0.93	-0.03	-0.68	-0.69	0.69
Net Debt	0.98	0.93		-0.85	0.81	0.87	0.81	0.99	0.89	-0.5	0.44	0.61	0.75	0.7	-0.22	0.72	0.55	0.8	-0.32	-0.61	-0.66	0.65
Retained Earnings	-0.76	-0.64	-0.85		-0.71	-0.61	-0.94	-0.84	-0.64	0.32	-0.4	-0.36	-0.95	-0.3	0.63	-0.33	-0.58	-0.47	0.73	0.5	0.56	-0.58
Accounts Payable	0.76	0.72	0.81	-0.71		0.52	0.85	0.77	0.57	-0.44	0.85	0.38	0.79	0.71	-0.1	0.62	0.24	0.69	-0.19	-0.11	-0.16	0.23
Net Receivables	0.94	0.95	0.87	-0.61	0.52		0.5	0.91	1.0	-0.43	0.08	0.46	0.42	0.75	0.01	0.84	0.6	0.88	-0.08	-0.86	-0.84	0.83
Good Will	0.71	0.61	0.81	-0.94	0.85	0.5		0.78	0.54	-0.34	0.62	0.35	0.99	0.35	-0.57	0.35	0.43	0.5	-0.66	-0.3	-0.31	0.45
Total Liab	0.99	0.94	0.99	-0.84	0.77	0.91	0.78		0.93	-0.47	0.38	0.56	0.72	0.7	-0.22	0.74	0.56	0.81	-0.31	-0.69	-0.72	0.72
Total Current Assets	0.96	0.97	0.89	-0.64	0.57	1.0	0.54	0.93		-0.43	0.14	0.47	0.46	0.77	-0.01	0.85	0.59	0.89	-0.09	-0.83	-0.82	0.82
Current Deferred Revenue	-0.49	-0.47	-0.5	0.32	-0.44	-0.43	-0.34	-0.47	-0.43		-0.26	-0.44	-0.25	-0.46	-0.11	-0.46	-0.3	-0.47	-0.01	0.2	0.22	-0.22
Common Stock	0.37	0.34	0.44	-0.4	0.85	0.08	0.62	0.38	0.14	-0.26		0.13	0.59	0.48	-0.04	0.29	-0.25	0.31	0.0	0.31	0.21	-0.21
Short Term Debt	0.56	0.5	0.61	-0.36	0.38	0.46	0.35	0.56	0.47	-0.44	0.13		0.26	0.31	-0.05	0.34	0.31	0.38	-0.14	-0.25	-0.24	0.29
Intangible Assets	0.64	0.52	0.75	-0.95	0.79	0.42	0.99	0.72	0.46	-0.25	0.59	0.26		0.24	-0.66	0.24	0.39	0.38	-0.73	-0.28	-0.31	0.41
Net Tangible Assets	0.79	0.86	0.7	-0.3	0.71	0.75	0.35	0.7	0.77	-0.46	0.48	0.31	0.24		0.49	0.95	0.27	0.91	0.4	-0.35	-0.38	0.34
Long Term Debt	-0.09	0.06	-0.22	0.63	-0.1	0.01	-0.57	-0.22	-0.01	-0.11	-0.04	-0.05	-0.66	0.49		0.42	-0.13	0.26	0.91	0.25	0.24	-0.34
Net Invested Capital	0.82	0.91	0.72	-0.33	0.62	0.84	0.35	0.74	0.85	-0.46	0.29	0.34	0.24	0.95	0.42		0.45	0.97	0.29	-0.52	-0.47	0.54
Short Long Term Debt	0.55	0.53	0.55	-0.58	0.24	0.6	0.43	0.56	0.59	-0.3	-0.25	0.31	0.39	0.27	-0.13	0.45		0.53	-0.46	-0.56	-0.5	0.6
Net Working Capital	0.88	0.93	0.8	-0.47	0.69	0.88	0.5	0.81	0.89	-0.47	0.31	0.38	0.38	0.91	0.26	0.97	0.53		0.11	-0.58	-0.5	0.65
Property Plant Equipment	-0.18	-0.03	-0.32	0.73	-0.19	-0.08	-0.66	-0.31	-0.09	-0.01	0.0	-0.14	-0.73	0.4	0.91	0.29	-0.46	0.11		0.26	0.22	-0.38
Capital Stock	-0.69	-0.68	-0.61	0.5	-0.11	-0.86	-0.3	-0.69	-0.83	0.2	0.31	-0.25	-0.28	-0.35	0.25	-0.52	-0.56	-0.58	0.26		0.94	-0.95
Capital Surpluse	-0.71	-0.69	-0.66	0.56	-0.16	-0.84	-0.31	-0.72	-0.82	0.22	0.21	-0.24	-0.31	-0.38	0.24	-0.47	-0.5	-0.5	0.22	0.94		-0.8
Short Term Investments	0.71	0.69	0.65	-0.58	0.23	0.83	0.45	0.72	0.82	-0.22	-0.21	0.29	0.41	0.34	-0.34	0.54	0.6	0.65	-0.38	-0.95	-0.8

Click cells to compare fundamentals

About Nutex Health Financial Statements

Nutex Health investors use historical fundamental indicators, such as Nutex Health's Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nutex Health. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	39.59	41.57
Tangible Book Value Per Share	33.81	35.50

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

IGIB	iShares 5 10 Year
SPTL	SPDR Barclays Long
SCHH	Schwab REIT ETF

Additional Tools for Nutex Stock Analysis

When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC